572
NEUROLOGIE3418040010757101158205267310370429450493
PRO856804001074591154
PRAXI1031804001074591148201221
/12988040010731
Neurol.1374804001075593139165209227243
praxi.1633804001074672114152170186
2024;25(6):441-4441836804001074487128168183227271293335357372415462500523569616663
/25448040010732
www.neurologiepropraxi.cz460880400107651332012142633073553814284484965465656086586857327828098518919109269661005
4441228020012657116175
HLAVNÍ341200012670127198263336370
TÉMA733200012657114204274
Tenektepláza34136001063062103135171205237272303345379421
v778360010636
liečbe8293600106294779114150182
ischemickej10273600106154782123155210227262298330357
NCMP139936001063974129164
a34055008332
prematurely389550083396196155188211250271306323356
terminated767550083225880141157197231254289330
randomized1120550083215595136176236252283318360
clinical1502550083324965104121154189205
trial.173055008322456295112126
Stroke.1879550083315274110340650083295973
2010;41:707-711.4276500833469101134147183214223257291324343375408437447
12.340750085366884
Huang4427500834482114152191
X,6517500833852
Cheripelli7217500834077112134149188224240255270
BK,1009750083357185
Lloyd1112750083324785117155
SM,12857500833287100
et14037500833456
al.1477750083324861
Alteplase1556750083415678112151167199226261
versus1835750083326687114152178
tenecteplase340850083215492126158182215253269300326360
for713850083185576
thrombolysis801850083215979116173212250265296323337363
after1176850083315074107128
ischemic1316850083154072109143200215246
stroke1574850083264970106136170
(ATTEST):1756850083185987123157190224245257
a34095008332
phase3879500833877109136170
2,5709500833447
randomized,630950083205391130168226241270304344356
open-label,9999500833777112150173189221260296311324
blinded1335950083395570108146181221
endpoint15699500833371110149188204241263
study.1845950083264987126157167
Lancet34010500832964101130159181
Neurology.53310500834373109130165180215252281292
2015;14:368-376.84110500833468100130141171202214249284319342374406438452
13.3401150085366883
Huang44211500834482114152191
X,65211500833851
MacIsaac72211500835487119134160193225258
R,99811500833549
Thompson106611500833272110168207234272311
JL,13951150083245770
et148411500833456
al.15581150083324860
Tenecteplase163711500833363101136169193227266282314341376
versus3401250083326687114151177
alteplase5301250083324769103142158190216251
in79412500831452
stroke8591250083264970107138172
thrombolysis:10441250083215980117175214253269300327342368380
an143712500833270
individual15201250083145291106138154193230262277
patient18101250083397293108143181202
data3401350083387092124
meta-analysis47713500835792115147170202240272287319346360386
of87613500833756
randomized9451350083215492131169227242271305344
controlled130213500833168106127149186202217251291
trials.1606135008321425890105131144
International1763135008315517110012015719221322834014500833572107122
Journal4751450083246096116153189204
of69114500833554
Stroke.7571450083315171106135165178
2016;11:534-543.94814500833468100131143174201210245278314336370406438451
14.3401550085366780
Katsanos4311550083356686112144180216241
AH,6821550083418495
Safouris7871550083326380116152172186210
A,100715500834153
Sarraj10701550083326383103134148
A,122815500834053
et129115500833354
al.13551550083314556
Intravenous1421155008315517191122152184220257293318
thrombolysis17491550083215777112168206243340165008315457184109
with4611650083516586123
tenecteplase5961650083225491125156179211249263294319353
in96116500831551
patients10251650083387090104137174194221
with12581650083516586123
large13931650083154665102136
vessel15411650083326490115149163
occlusions:17161650083386998112148173187223260285296
systematic3401750083265783105137193224245259289
review642175008320538498132181
and83617500833268106
meta-analysis.95417500835891112144165196232263277308333347371384
Stroke.13501750083314968101129158169
2021;52:308-312.15291750083346798128135169201212246279313334365395423434
15.3401850085366883
Kvistad4361850083356480106129162201
CE,6501850083397285
Næss74818500834498124151
H,91218500834457
Helleberg9811850083447995110144184219240278
BH,12721850083358093
et137818500833356
al.14461850083324760
Tenecteplase151918500833363101136169193226265281313340374
versus190618500833266873401950083266288
alteplase4401950083324769102140156187213247
for7001950083185576
the7881950083215993
management89419500835688125157195229286321358379
of128519500833756
acute135319500833263100122155
ischemic15211950083144071109143200215246
stroke17791950083264970106136169
in196119500831451
Norway34020500834583105158191222
(NOR-TEST57620500831964112148170200234268302
2,89320500833447
part9552050083387192117
A):10872050083416072
a1173205008332
phase122020500833978110136171
3,140620500833446
randomized,14672050083215492131169227242271306345358
open-184020500833776112150172
-label,3402150083213769109144160172
blinded5302150083395469107146181221
endpoint,76921500833472111150189204242264277
non-inferiority106421500833775114136152190209243265280318340356378412
trial.1493215008322445991107119
Lancet163021500832964101130159181
Neurology.1825215008343731091301653402250083145086116127
2022;21:511-519.48222500833468101136148183215223258289317336370401431442
16.3402350085366985
Li43923500833147
S,49923500833345
Pan55823500833567105
Y,67623500833544
Wang73323500835789127166
Z,91223500833851
et97623500833457
al.10462350083324760
Safety11192350083336685119141175
and130723500833270109
efficacy1430235008334527088120153185218
of166223500833756
tenecteplase173223500832155931281611852192583402450083154774109
versus4662450083326687115152178
alteplase6622450083324770103143158191217252
in93224500831552
patients10022450083397294109144182203231
with12512450083506688127
acute139524500833264102125158
ischemic15712450083154173111146204219251
stroke18402450083264971108138173
(TRACE):3402550083195694138178212232244
a606255008332
multicenter,65425500835997113136152185220259281316338348
randomized,10232550083215594134173233249279314354368
open141225500833878115154
label,15872550083154989125141154
blinded-17632550083395571110150186226249
-endpoint3402650083215795134174212228266287
(PROBE)6432650083185489137173206226
controlled88526500833168106128149186202217252292
phase119226500833977110136171
II137826500831530
study.14242650083264987126158168
Stroke16072650083315071105135165
Vascular17842650083356892121157172208228
Neurology.34027500834373109130165180215252281292
2022;7:47-53.64527500833468101136148181191226258276310343356
17.2140550085366776
Logallo22295500833168108140155170208
N,24505500834457
Novotny25205500834482114151173211242
V,27745500833645
Assmus2831550083416995153190216
J,30605500832436
et31095500833456
al.3178550083314659
Tenecteplase32505500833263101136168192226265280312339373
versus3636550083326687114151177
alteplase2140650083324770104143159191218253
for2414650083185677
management25126500835790128160199234293328366388
of29206500833757
acute29976500833264102125159
ischemic3176650083154173112147205220252
stroke3449650083264970108139173
(NOR-36426500831964112149170
-TEST):2140750083215185119153175187
a234575008332
phase23927500833977109136171
3,25817500833446
randomized,2644750083215492131169227243272306345358
open-label,30207500833776112150173189221260296312324
blinded3361750083395570108147182221
endpoint360075008334721111501892140850083155374
trial.222985008322435991106119
Lancet23648500832964101130159181
Neurology.25578500834373109130165180215252281292
2017;16:781-788.28628500833468100129139169200213246280311330361395430444
18.2140950085367086
Ma22479500835588
Y,23569500833544
Xiang2420950083395486125164
H,26059500834558
Busse26849500833573100127162
JW,2867950083258493
et29819500833457
al.3059950083324861
Tenecteplase31409500833364103138171196230270286318345381
versus3542950083316688115153180
alteplase3742950083324821401050083225695111143170205
for23661050083185678
acute246410500833264102125159
ischemic26431050083154174112147205220252
stroke:29161050083264971108139173186
a3123105008331
systematic31701050083265986109143201233255271303
review34931050083215588104138190
and370310500833270110
meta-analysis214011500835996119154177211251285301334363378406
of256911500833859
randomized26511150083215595136176236253283319360
and303411500833372113
non-randomized317011500833979119143166200240281321381398428464505
studies.3698115008327519121401250083385388115128
J2281125008324
Neurol.231812500834273109129164179192
2024;271:2309-2323.252312500833468101133145180213245254289324358393417448483515550563
19.21401350085366983
Menon224413500835590129167206
BK,24711350083357186
Buck257813500833674106137
BH,27351350083368194
Singh28501350083334886125164
N,303413500834558
et311313500833457
al.31901350083324861
Intravenous3272135008315537597130162196235274312339
tenecteplase3631135008322569513016321401450083225595111143169204
compared236414500833168126165198219254293
with26771450083506688126
alteplase28231450083324769103142158191217252
for30951450083185677
acute319214500833164101124158
ischemic33691450083154173111146204219251
stroke36401450083264970108138172
in214015500831553
Canada220615500834073111143182215
(AcT):24341550083196091120142154
a2601155008332
pragmatic,26491550083386093132190222244259291304
multicenter,296715500835795110132148180213251273307328338
open-label,331815500833777113151173189222261296312324
registry-linked,365615500832155941091362140165008322437799115130168198233272285
randomized,24391650083215492131169227242271306345358
controlled,281116500833168107128150187203218253292305
non-inferiority313016500833876114137153191210244265281319341356379412
trial.3557165008321435890106119
Lancet.3690165008329641012140175008329587992
2022;400:161-169.224717500833468101136148183219255268298329359378409440474485
20.21401850085367287
Muir224418500835492107129
GFK,238918500834477111126
Ford25321850083326991129
I,267718500831528
Wardlaw272118500835889110148164196247
JM,29841850083247993
et309318500833456
al.31661850083324760
Tenecteplase324318500833263101136169193227266282314340375
versus36351850083326687114152178
alteplase21401950083324770103142158191217252
for24101950083185678
acute250619500833164101124158
stroke26821950083264970108138172
within28721950083516789127142180
4.530701950083344782
hours317019500833876114135162
of335019500833857
onset:342519500833776102137159173
the36161950083215994
second372819500832661214020500833167104142
alteplase-tenecteplase22942050083324668101139155186212246268290323360394426449482520536567593627
trial2933205008321425788103
evaluation30482050083346597112148180201216253290
for33502050083185576
stroke34382050083264869105135168
thrombolysis3618205008322597911617321402150083397793125152167193
(ATTEST-2).23482150083196089126161194229247278296307
(2023).26702150083195387120154172182
21.21402250085367185
Ouriel224722500834887110126162179
K.244922500833551
Safety25232250083326787123146181
and272622500833372112
efficacy2861225008334547290123157191226
of310922500833858
various31902250083326688105144184211
thrombolytic34242250083226183122182223263280313339355389
agents.214023500833273110150173202217
Reviews23802350083356699115146198224
in262323500831452
Cardiovascular26942350083397597133150187218255280311348365402424
Medicine.313723500835486124140171187225257271
2002;3(Suppl342723500833571109143157194213247286327368385
2):S17.21402450083345365100131161168
22.21402550085367288
Parsons22432550083356788115154192218
M,247625500835468
Spratt25582550083337193126148172
N,274425500834558
Bivard28162550083365183116138176
A,300625500834155
et307525500833457
al.31462550083324760
A3220255008341
randomized32772550083205391130169227242271305345
trial3636255008322435991106
of375625500833857
tenecteplase21402650083225593128160184218257273305331366
versus25192650083316586113150176
alteplase27082650083324769103142158190216251
for29722650083185677
acute306226500833163101123157
ischemic32322650083144072110145203218249
stroke.34942650083264970108138172184
New369126500834373122
England214027500833167102117153189225
Journal23782750083246096116153189204
of259427500833554
Medicine.266027500835384120134164179215245258
2012;366:1099-1107.293127500833468100130142177212247260290321356391415446474505538544
23.3940550085367286
Roaldsen40395500833573106121159185220257
MB,43095500835490102
Eltoft4424550083324769105124149
A,45865500834054
Wilsgaard4653550083577388113152184216236274
T,49405500833241
et49935500833456
al.5062550083314659
Safety5134550083326483117139172
and53195500833169108
efficacy54395500833452708711915239406500833165
of40186500833756
tenecteplase4087650083225694129161186219258274307333368
in44686500831553
patients4534650083387193108143181203230
with4777650083516689127
wake-up49176500835183114148171210249
stroke5179650083264971108138173
assessed5365650083315884119146173208247
by39407500833970
non-contrast40277500833775114136170207245267288321348371
CT44157500834075
(TWIST):45077500831954116131164198220232
a475675008331
multicenter,48037500835795110132148180213251273307328338
open-label,51577500833877113151173190222261297312325
randomized549875008321549239408500833876134150179213252
controlled42088500833168106128149186202217252292
trial.451585008322435991106119
Lancet46508500832964101130159181
Neurology.48438500834373109130165180215252281292
2023;22:117-126.51488500833468101136147182217230259287316335366396429443
24.3940950085367186
Ross40449500833574100127
AM.41899500834196110
New43179500834580131
plasminogen4466950083395587114171186224262302337375
activators4859950083326488103136169191228249276
a515395008332
clinical5200950083324762100115147180195
review.5413950083215587103137189199
Clinical39401050083385267103118148183197
Cardiology.41501050083387393127142178193229265294306
1999;22:165-171.447110500833464100135148183217230260291325347378407439449
25.39401150085367184
Serebruany40361150083326686119156177213244281310
VL,43581150083366779
Malinin444911500835586100113150163200
AI,46611150083415466
Callahan4739115008339718599129166197234
KP,49841150083357174
et506911500833455
al.51361150083324657
Effect52051150083335069102134156
of537311500833755
tenecteplase5440115008322549112415539401250083225492106137162196
versus41501250083316484110146170
alteplase4334125008332466799137152182208241
on458912500833774
platelets46771250083395384104137151184205232
during49221250083387494108145183
the51181250083225992
first5224125008317345479101
35339125008334
hours538712500833774111131157
of555712500833855
treatment39401350083224274105125182216252272
for42291350083195575
acute43211350083326399120153
myocardial449113500835786122154185205242255286300
infarction:48081350083155168100120150173186223260271
The509613500833270104
Assessment52171350083416792126151177233267303323
of555713500833855
the39401450083215790
Safety40391450083326380112133164
and421314500833167104
Efficacy4326145008332486683113144174205
of454014500833754
a4604145008331
New464714500834477126
Thrombolytic47821450083326988123179216253267296319332362
Agent515414500834076109145164
(ASSENT-2)53271450083195890120150192224241269285
platelet39401550083395384104137151184205
substudy.41581550083266299125146183221251260
American443115500833892121140154182215251
Heart469115500834372106125146
Journal.48471550083245994113148182196207
2003;145(4):636-642.506415500833467102133143172202233249281297307341374407429465500531542
26.39401650085367187
Tanswell40461650083336199125177211227242
P,430616500833540
Modi436416500835593133148
N,453016500834558
Combs460616500834077135174201
D,482516500834657
Danays490016500834577116148179206
T.512416500833342
Pharmacokinetics5184165008335731051261852172492863173333714063940175008322376997
and405617500833270109
pharmacodynamics418517500833977109131189221253290330362401433491506538566
of477017500833857
tenecteplase48471750083215593128161185219258274306333368
in523417500831553
fibrinolytic5307175008317337294110148186202233258274306
therapy39401850083226095116149188219
of417618500833756
acute424918500833164101124158
myocardial442318500835788126158191212250266298313
infarction.47521850083155372105126157181197235273286
Clinical50551850083385267103118148183197
Pharmacokinetics.52661850083336910412518121724628131032639401950083366688102132157171
2002;41(15):1229-1245.412419500833468104137150184215230261291310322351381416450474505535566599611
27.39402050085367079
Wang403120500835788125163
Y,420720500833543
Li426220500833146
S,432120500833244
Pan437820500833566103
Y,449420500833543
et454920500833455
al.,4617205008331465971
TRACE-2470120500833268111149181202233
Investigators.49462050083155283117143166181219251272308329356369
Tenecteplase53282050083326210013416619022326239402150083154671105
versus40572150083326585112148173
alteplase42422150083314668100139154185211245
in449921500831451
acute45622150083316299121153
ischemic47272150083154071108142199213244
cerebrovascular49832150083316384117155176212243275301332369383415435
events54302150083336598135156182
(TRACE-2):39402250083195592135174207229260278290
a4251225008332
phase429822500833978110137172
3,449122500833446
multicenter,455822500835795111133149181215253275309330340
open-label,491922500833777113151173190222262298313326
randomized52652250083215493132170229244273308347
controlled,394023500833168107128150187203218253292305
non-inferiority426023500833876114137153191210244265281319341356379412
trial.4688235008321435890106119
Lancet.482223500832964101130159181193
2023;401:645-654.502823500833468101136147182218250258294330363385422456491504
28.39402450085367288
Xiong40482450083385391130169
Y,423724500833543
Wang430024500835889127166
L,448624500833245
Li455224500833146
G,461824500834458
et469624500833456
al.47722450083324760
Tenecteplase485224500833364102137169194227267282315341376
versus52482450083326687115152178
alteplase5446245008332487010414339402550083154874110
for40712550083185678
acute417025500833265103126160
ischemic43512550083144174112147206221254
stroke:46252550083275072110141175188
a4834255008332
meta-analysis488225500835793115149171204243275291323350366392
of529525500833757
phase537325500833978110137173
III55672550083143045
randomized39402650083215594135174234250280315356
trials.4317265008322446194110137151
Stroke44892650083315273109139170
Vascular46762650083367095125162177214235
Neurology.492926500834375112133169184221259289300
2023;28:svn2023-002396.525126500833570104140152188223236264298338394027500833468101136158195231264299332367381
PŘEDPLATNÝM42651800248116231339479594693827922105811781344
ČASOPISU181051800248119251359500617670777911
NA42654300248138267
ROK73454300248118260383
2025115754300248111220326434
ZÍSKÁTE:163254300248115172278399536631736788
20%42657400252115227411
slevu8775740025290148256363482
na139957400252119228
kongresy*16675740025211523034946754865674685525255760024183
pořádané4265970019391179230306395470557636
společností10965970019364152240277356428515601662715751
SOLEN18805970019379188263339442
5×4266260015767138
Neurologie5926260015785150221262332362433505534598
pro12186260015774116186
praxi14316260015774116178238268
ve17276260015762125
vaší18796260015763125174203
schránce21106260015751109179220282353411473
Tematická4266460015765120228289330359416475538
suplementa9926460015751121194224288396460531572635
Přístup4266650015769109139188231301374
do8286650015773143
archivu9996650015763104160231260321393
časopisu14196650015758120170241314344393463
on-line19106650015771142183215243314378
*27625770010937
platí2818577001095274117147168
pro3005577001095181131
kongresy2789586001094291141192222267303347
uvedené2803595001095094138190236286332
v27336040010943
seznamu2795604001093682121172215290340
Objednávejte42677700199115211255340435529613694776821880964
www.neurologiepropraxi.cz426797001217415022724430035140643949351757262965270275979284790493798510331057107711221167
predplatne@solen.cz426808001215790140197254278326358413464538578633657707763784829874
Už41944800377209354
máte83544800377261426539701
předplaceno?159844800377183305467653836925109012241386156717441871
Cena4267180020196180276364
předplatného82271800201971622483474454925806407378239201014
na18677180020196184
rok20827180020165159251
202523657180020191182270360
142673500277126
98058073500277126250377
Kč100073500277142236
(512807420019345122
čísel/rok)14367420019372107168247284337384470544589